Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_assertion type Assertion NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_head.
- NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_assertion description "[MIA and GW112 were overexpressed in 10 (25%) and 22 (55%) of 40 GC samples, and the overexpression of these two genes was associated with tumor stage, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_provenance.
- NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_assertion evidence source_evidence_literature NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_provenance.
- NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_assertion SIO_000772 16210872 NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_provenance.
- NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_assertion wasDerivedFrom befree-2016 NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_provenance.
- NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_assertion wasGeneratedBy ECO_0000203 NP516933.RAQ9QaX9Swdx1fsVXYtJts_XAfgOPN8VM56-4HnM_Y0HE130_provenance.